DVS Sciences

DVS Sciences raises $14 million, largest round in Canada life sciences, to expand CyTOF sales

Monday, August 29, 2011


DVS Sciences, which invented and manufactures an instrument enabling biomarker analysis for scientific research, clinical trials and personalized medicine, has raised $14.6 million in series A financing. This is the largest venture-backed series A equity raised in Canada’s life sciences and medical technology fields in recent years, and is almost twice the average series A funding in the U.S., the company said.

[Read More]